M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis

Journal of the National Cancer Institute

Volumn 107, Issue 9, 2015, Pages

  De La Fuente, Alexandre ^a   Alonso Alconada, Lorena ^a   Costa, Clotilde ^a   Cueva, Juan ^a   Garcia Caballero, Tomas ^a   Lopez Lopez, Rafael ^a   Abal, Miguel ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES FLUID; CANCER CELL; CELL ADHESION; DEVICE REMOVAL; EXOSOME; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTATIC TRAP; MOUSE; NONHUMAN; OVARY CANCER; OVARY METASTASIS; PERITONEAL CAVITY; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEOMICS; SURVIVAL RATE; TISSUE SCAFFOLD; ANIMAL; EXPERIMENTAL NEOPLASM; KAPLAN MEIER METHOD; OVARY TUMOR; PATHOLOGY; PERITONEUM TUMOR; SECONDARY; TUMOR CELL LINE;

ANIMALS; ASCITIC FLUID; CELL ADHESION; CELL LINE, TUMOR; EXOSOMES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MICE; NEOPLASMS, EXPERIMENTAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS;

EID: 84942257226     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv184     Document Type: Article

References (22)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674.
2. Sleeman JP, Christofori G, Fodde R, et al. Concepts of metastasis in fux: the stromal progression model. Semin Cancer Biol. 2012;22(3):174-186.
3. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specifc colonization. Nat Rev Cancer. 2009;9(4):274-284.
4. Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer. 2009;9(4):285-293.
5. Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol. 2011;21(2):139-146.
6. Sleeman JP. The metastatic niche and stromal progression. Cancer Metastasis Rev. 2012;31(3-4):429-440.
7. Fevrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol. 2004;16(4):415-421.
8. Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18(6):883-891.
9. Zoccoli A, Iuliani M, Pantano F, et al. Premetastatic niche: ready for new therapeutic interventions? Expert Opin Ther Targets. 2012;16(Suppl 2):S119-S129.
10. Colombo N, Van Gorp T, Parma G, et al. Ovarian cancer. Crit Rev Oncol Hematol. 2006;60(2):159-179.
11. Ihemelandu CU, Shen P, Stewart JH, et al. Management of peritoneal carcino-matosis from colorectal cancer. Semin Oncol. 2011;38(4):568-575.
12. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9-29.
13. Sodek KL, Murphy KJ, Brown TJ, et al. Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis. Cancer Metastasis Rev. 2012;31(1-2):397-414.
14. Helland O, Popa M, Vintermyr OK, et al. First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma. PLoS One. 2014;9(3):e89527.
15. Tan DS, Agarwal R, Kaye SB. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol. 2006;7(11):925-934.
16. Steinkamp MP, Winner KK, Davies S, et al. Ovarian tumor attachment, invasion, and vascularization refect unique microenvironments in the peritoneum: insights from xenograft and mathematical models. Front Oncol. 2013;3:97.
17. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86-100.
18. Burleson KM, Casey RC, Skubitz KM, et al. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell mon-olayers. Gynecol Oncol. 2004;93(1):170-181.
19. Niedbala MJ, Crickard K, Bernacki RJ. Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion. Exp Cell Res. 1985;160(2):499-513.
20. Scarlett UK, Conejo-Garcia JR. Modulating the tumor immune microenvi-ronment as an ovarian cancer treatment strategy. Expert Rev Obstet Gynecol. 2012;7(5):413-419.
21. Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13(4):273-282.
22. Koppe MJ, Boerman OC, Oyen WJ, et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006;243(2):212-222.